When you go to “COOKIES INCL. ALLOW US SERVICES” click, you agree to the storage of cookies on your device to improve website navigation, analyze site usage, and support our marketing efforts. For more information, see our Privacy statement.

3.2.2025

Haemo Pharma as ADMIRA Wacker's new healthcare partner

Eisenstadt, 03.02.2025 - Haemo Pharma is pleased to announce its partnership with the traditional football club ADMIRA Wacker. As an official health partner, Haemo Pharma provides the club with state-of-the-art technologies and innovative therapy concepts to promote the health of the players, optimize regeneration and prevent injuries.

Representatives from Haemo Pharma and ADMIRA Wacker present a sponsored shirt on the pitch, with a soccer ball in hand and an advertising band in the background.

Innovative technologies for top performance

As part of the partnership, Haemo Pharma provides advanced therapy systems, including the innovative IMPACT cell therapy platform as well as the modern WINBACK-TECAR therapy device BACK4, which is already used by top international clubs such as FC Bayern Munich and Paris Saint-Germain. These technologies enable precise and effective treatments that both strengthen joint health and quickly restore mobility following injuries.

“Joint health is of central importance for athletes — it is the basis for sustainable performance and injury prevention. Our goal is to keep Admira players healthy and performing in the long term through preventive measures and to enable them to return to sport more quickly after injuries“, explains Mag. Markus Mateyka, managing director of Haemo Pharma.

WINBACK - cutting-edge technology from France

Die WINBACK TECAR-Therapy helps players recover after intensive games and training sessions. High-frequency energy transfer promotes blood circulation and metabolism, reduces pain and accelerates the healing of injuries. WINBACK-TECAR therapy is versatile and can be optimally combined with manual therapy methods to effectively treat a wide range of complaints such as acute injuries, chronic pain and post-operative rehabilitation.

IMPACT - platform for autologous cell therapies

Die IMPACT The platform enables the production of autologous, i.e. endogenous cell therapies, to accelerate the healing of joint injuries and promote long-term joint health. Growth factors and anti-inflammatory cytokines are extracted from the player's blood, processed and then injected directly into the affected joint to specifically support the healing process.

About Admira Wacker

Admira Wacker is a soccer club steeped in tradition that forms a close-knit community of players, coaches, employees and fans. Characterized by trust, respect and openness, the club stands for cohesion and mutual support. The Admira Academy forms the heart of the club and is dedicated to the promotion and development of young talent.

The club combines strong roots with a forward-looking vision and lives by values such as fair play, tolerance and solidarity. With a down-to-earth attitude and professionalism, Admira Wacker stands for modern, successful soccer and remains a reliable partner and inspiring place for everyone who loves sport.

About Haemo Pharma

Haemo Pharma was founded in 2006 by Prof. Dr. Peter Mateyka and Markus Mateyka with the vision of improving people's quality of life through innovative products. The family-owned company specializes in the distribution of high-quality original products in the fields of orthopaedics, traumatology and gastroenterology and supplies hospitals, pharmacies and wholesalers in Austria and abroad. In the orthopaedic specialist area in particular, the focus is on regenerative medicine and joint preservation, which is why Haemo Pharma has been certified as a tissue bank and tissue collection facility since 2018.

Für weitere Informationen kontaktieren Sie bitte:

More posts

Product Update

Long-term study proves lasting success with HyaloFast

A recent long-term study (Whyte et al. 2024) confirms the sustainable effectiveness of HyaloFast.
Product Presentation

Stem cell therapy for degenerative joint diseases

In an Ö24 interview, Prof. Dr. Zimpfer provides insights into stem cell therapy and new approaches .
Sponsoring

Lotteries Sporthilfe Gala 2024: A Celebration of Austrian Sports Talent

Outstanding local athletes were honored at the 28th LOTTERIES Sports Aid Gala in the Wiener Stadthalle.

Make evidence-based decisions

Learn more about our scientifically researched products. Please feel free to contact us for further information.